If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information:
Olumiant Summary of Product Characteristics (SmPC)
Olumiant® ▼ (baricitinib): Effect of food on administration
Administration with meals was not associated with a clinically relevant effect on exposure.
is to be taken once daily with or without food and may be taken at
any time of the day.1
with meals is not associated with a clinically relevant effect on
assessment of food effects in healthy subjects showed that a high-fat
meal decreased the mean area under the curve and maximum serum
concentration of BARI by approximately 11% and 18%, respectively, and
delayed the time to reach maximum serum concentration by 0.5 hours.2
clinical studies, BARI was administered without regard to meals.2
can be taken at any time of day or night. It is best to take BARI at
the same time every day.1
Olumiant [summary of product characteristics]. Eli Lilly Nederland
B.V., The Netherlands.
Data on file, Eli Lilly and Company and/or one of its subsidiaries.
medicinal product is subject to additional monitoring. This will
allow quick identification of new safety information. Healthcare
professionals are asked to report any suspected adverse reactions.
Date of Last Review:April 30, 2019
Was this answer helpful to you?
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at firstname.lastname@example.org